Scott Bahlavooni

Scott Bahlavooni is a seasoned professional in clinical programming with extensive experience in the life sciences industry. Currently serving as a Principal Clinical Programmer at Nektar Therapeutics since October 2019, Scott previously held roles such as Life Sciences Consultant and Senior Consultant at independent and consulting firms. From November 2017 to May 2019, Scott contributed to PhUSE as Co-Director of Working Groups on the Board of Directors. Prior positions include Principal Standards Analyst at Biogen and roles in data standards and clinical programming at Genentech and Quintiles. Scott Bahlavooni earned a Bachelor of Science in Mathematics and Statistics from Bloomsburg University of Pennsylvania.